Effect of 5-HT Receptor Agonists or Antagonists on Hypothalamic 5-HT Release or Colonic Temperature in Rats
Mengjuan Lin, H. J. Liu
Abstract
Mengjuan Lin, H. J. Liu
Abstract
Intraperitoneal administration of either l-(3-chlorophenyl)-piperazine (5-HT1 receptor agonist), 8-hydroxy-DPAT (5-HT1A receptor agonist), CGS-12066B (5-HT1B receptor agonist), DOI (5-HT2 receptor agonist) or 2-methyl-serotonin (5-HT3 receptor agonist) produced dose-dependent decrease in both the colonic temperature and the hypothalamic 5-HT release measured by in vivo voltammetry in unanaesthetized rats. On the other hand, intraperitoneal administration of propranolol, S(-) (5-HT1 receptor antagonist)or ketanserine (5-HT2 receptor antagonist) caused dose-dependent increase in both the colonic temperature and the hypothalamic 5-HT release in rats.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Intraperitoneal administration of either l-(3-chlorophenyl)-piperazine (5-HT1 receptor agonist), 8-hydroxy-DPAT (5-HT1A receptor agonist), CGS-12066B (5-HT1B receptor agonist), DOI (5-HT2 receptor agonist) or 2-methyl-serotonin (5-HT3 receptor agonist) produced dose-dependent decrease in both the colonic temperature and the hypothalamic 5-HT release measured by in vivo voltammetry in unanaesthetized rats. On the other hand, intraperitoneal administration of propranolol, S(-) (5-HT1 receptor antagonist)or ketanserine (5-HT2 receptor antagonist) caused dose-dependent increase in both the colonic temperature and the hypothalamic 5-HT release in rats.
Key concepts: Agonist, 5-HT receptor, Receptor antagonist, Endocrinology, Chemistry, Internal medicine, Pharmacology, Receptor